Tuesday, April 14, 2026

 


The New Era of Pharma Quality Management: Secure, Cloud‑Powered, AI‑Enabled, and Built for Zero‑Defect Operations


Pharmaceutical organizations are under more pressure than ever. Regulatory expectations continue to rise, supply chains are more complex, and the cost of quality failures can reach millions. In this environment, companies need more than a traditional Quality Management System — they need a platform that is accurate, reliable, secure, cloud‑ready, and intelligent.
That’s exactly why we enhanced the EAPharmics Quality Management System (QMS) and modernized the EAHelp experience at


EAPHARMICS eSTAR Latest Version Details


The new version preserves the familiar look and structure your teams already know, but underneath the surface, it’s a next‑generation platform engineered for speed, compliance, and AI‑driven decision support.


🌐 Cloud‑Native. Secure by Design. Built for Global Pharma.
The enhanced EAPharmics QMS is now fully optimized for cloud deployment, giving organizations:

  • Scalability across global manufacturing and QA operations
  • High availability with redundant, fault‑tolerant architecture
  • Enterprise‑grade security with encrypted data flows and hardened access controls
  • Zero‑downtime updates for continuous improvement
  • Faster onboarding for new sites, partners, and CMOs
Whether deployed in a private cloud or a validated public cloud environment, the platform ensures data integrity, audit readiness, and regulatory compliance at every step.


🤖 AI Capability That Elevates Quality, Not Replaces It
The new AI layer transforms the QMS from a passive record‑keeping system into an active quality intelligence engine.


AI‑powered features include:

  • Automated deviation triage
  • Predictive quality risk scoring
  • Smart CAPA recommendations
  • AI‑assisted document summarization
  • Pattern detection across batches, sites, and suppliers
  • Faster root‑cause analysis
These capabilities help QA teams move from reactive to proactive, reducing cycle times and preventing issues before they escalate.


📘 EAHelp: Same Familiar Look, Completely Modernized
Your users don’t need to relearn the system.


The updated EAHelp site retains the original structure — but now includes:

  • Cleaner navigation
  • Faster loading
  • Updated content
  • AI‑generated contextual help
  • Step‑by‑step guidance for every module
  • Clear explanations of icons, menus, workflows, and compliance steps
This ensures zero disruption for existing users while delivering a modern, intuitive learning experience.


🔒 Accuracy, Reliability, and Compliance at the Core
Pharma quality systems must be:

  • Accurate — no data drift, no inconsistencies
  • Reliable — always available, always validated
  • Secure — protected from unauthorized access and cyber threats
  • Traceable — full audit trails and version control
  • Compliant — aligned with FDA, EMA, MHRA, WHO, and GxP expectations
The enhanced EAPharmics QMS is engineered to meet these requirements with:
  • End‑to‑end data validation
  • Role‑based access control
  • Immutable audit logs
  • Automated compliance checks
  • Configurable workflows aligned with global regulations
This is a system designed for zero‑defect operations and regulatory confidence.
📈 Business Impact: Why Customers Are Upgrading Now
Organizations adopting the enhanced platform are seeing measurable improvements:
  • 40–60% faster deviation and CAPA cycle times
  • Reduced audit findings due to consistent, validated workflows
  • Higher operational efficiency with AI‑assisted tasks
  • Lower IT overhead through cloud deployment
  • Better visibility across global quality operations
In a competitive market, these advantages translate directly into cost savings, reduced risk, and faster time‑to‑market.


🌟 The Future of Pharma Quality Starts Here
The enhanced EAPharmics QMS is more than an upgrade — it’s a transformation.
A secure, cloud‑powered, AI‑enabled platform that helps pharmaceutical companies:

  • Improve product quality
  • Strengthen compliance
  • Reduce operational risk
  • Empower QA teams
  • Accelerate digital transformation

EAPHARMICS 

Friday, April 17, 2020

Eapharmics - Stability Software for Pharmaceuticals including Vaccines

Pharmaceutical Electronic Stability Testing Analysis and Reporting -
eSTAR - Manages Stability Testing, Data Analysis and Reporting


As various pharmaceutical companies with hard working scientists in various fields working towards finding a perfect vaccine for COVID-19, it is as important to study the stability of these vaccines to estimate the effectiveness of the available vaccine for the duration  of effectiveness, simultaneously.

STABILITY of the VACCINES -



Important aspects of Stability of Vaccines during all stages of  development and is easily recorded and analyzed in the 
EAPHARMICS eSTAR Pharmaceutical Stability Software.

From early stages of development to final stages of stability report, Stability is simplified in the eSTAR application with Secure, Reliable and Accurate Stability Software Application.

Key Aspects of Vaccine Stability:
.
Vaccine Stability study Design,
Vaccine Stability in different climate conditions:
Climate Zone I:
Temperate


Climate Zone II:
Mediterranean, Subtropical


Climate Zone III:
Hot, Dry

Climate Zone IV:
Hot, Humid

Stability evaluation at different stages of production and use,
Stability indicating parameters,
Stability frequency testing,  
Cumulative age of an antigen and effectiveness of Vaccine,
Stability studies for clinical trial, 
Stability evaluation for during and after licensing,
Stability testing including assays for lot release,
Stability Test Results, 
Stability Data Analyses and Evaluation including Statistical Analysis,
Stability studies and analysis of the data to support manufacturing changes, and 

Data analysis Stability evaluation of combined vaccines.





Quality labeling is important for vaccine storing objects and should adhere to compliance authorities (Such as United States Food Drug Administration-USFDA, Therapeutic Products Programme-TPP, International Conference on Harmonisation-ICH, Therapeutic Goods Administration-TGA, National Institute of Health Sciences - NIHS and European Medicines Agency EMA of European Union EU and other agencies) requirements.

Important details including expiry date should be clearly detailed in the label. 

Sensitivity of vaccine to environmental factors (Light and Temperature effects) and recommended preventive measures details should be added in Labels.


EAPHARMICS also provides complete Data Governance and Regulatory Compliance  for Pharmaceutical Industry.


EAPHARMICS wishes all pharmaceutical companies to produce a speedy stable Vaccine against Covid-19 and provides support for the stability software needs for the vaccines.



EAPHARMICS

Sunday, December 18, 2016

Stability Software



EAPHARMICS eSTAR - Stability Software - Easy stability data management.



Data security with power of Oracle Database.



Best Labeling for stability



Excellent Stability report.


Best electronic Stability Testing Analysis and Reporting.




Monday, November 17, 2014

Stability Guideline for Stability testing fulfilled by Stability Software - EAPHARMICS eSTAR




Electronic Stability Testing Analyses & Reporting (eSTAR) by EAPHARMICS

Software Details
New Study Login:

Information - Log in Drug Information - New Study


Stability Maintenance Modules:

Specifications:

Test  Information - Along with Protocol and Intervals
   Stress Testing - Temperature
                           - Humidity
                           - Photostability



 Testing Frequency -  Three points - 0, 3, 6 or  Four points 0, 6, 9, 12 or Customized points

      Storage conditions -Data Dictionary and select it in New Study Login

Batches -
      Stability tests should be done at least on 3 batches

Data Dictionary
        - Container Closure Systems along with all information


Stability Commitment:

    Alerts are provided in the system, so stability tests are not missed.
Proper Stability Data is obtained and stored in the system


Evaluation - Data Analyses - Graph View, Upper Level, Lower Level, Linear regression



Label - More on Label Printing -
    Label Printing

Stability Summary Final Report ready for submission to FDA:


RELIABLE SECURE & ACCURATE 
Data maintained in ORACLE Database 

More Information - www.eapharmics.com


Final Note: Stability testing should be done for all pharmaceutical ingredients,products and data should be readily available to regulatory authorities in all parts of the World with no exceptions.


Makesh Karuppiah, Ph.D
Senior Scientist

Friday, August 31, 2012

Ketamine ScheduleIII Controlled Substance


Ketamine is a controlled substance. Specifically, it is a Schedule III substance under the Controlled Substances Act. Schedule III drugs, which include codeine and anabolic steroids, have less potential for abuse than Schedule I (heroin) or Schedule II (cocaine) drugs. However, abuse of Schedule III substances may lead to physical or psychological dependence on the drug.

Recently read about these Ketamine are produced without any accountability. Authorities have to strictly enforce accountability on these type problematic drugs. Each and every tablet should be accounted for, so that it does not spoil the life of young people all over the world. EAPHARMICS eSTAR stability program allows to account each and every unit of the drug at least in stability level. This should be taken into real world so that every tablet is accounted for and not end with a healthy individual.
                                                                              Ketamine


There are so many side effects this Ketamine can cause. A careless person's greed will lead to health degradation of youth's health all over the world.